Peplin Completes Enrollment in Actinic Keratosis Trial - FDA news (subscription)
Peplin Completes Enrollment in Actinic Keratosis TrialFDA news (subscription), VA - 1 hour agoAustralian drugmaker Peplin announced the completion of enrollment in its Phase II trial of PEP005 topical, a potential treatment of actinic keratosis. …
Read full story